Skip to main content
. 2018 Jun 26;2018:5083234. doi: 10.1155/2018/5083234

(a) Presentation, treatment, and outcome of primary CNS mature B-cell lymphomas presented as an amyloidomas published in literature

Reference Age/sex Symptoms at presentation Duration of symptoms site Clinical diagnosis Treatment Follow-up Diagnosis rendered
(1) Lehman et al. [1] 63F Focal sensory seizure- trigeminal neuralgia and mild right sided hearing loss 3 years Dural, frontal lobe Meningioma Surgical resection of the largest mass, radiation therapy 8 months- alive with disease, imaging showed no change in the size of the amyloid mass Primary CNS Marginal zone lymphoma

(2) Pace et al. [2] 46F Seizures Acute onset Left frontal lobe Oligodendroglioma or metastasis Surgical resection only 24 months- no evidence of disease Primary CNS lymphoplasmacytic lymphoma

(3) Tu et al. [3] 49 M Seizures NR Dural, left frontal NR Methotrexate, recurrence treated with fludarabine 7.6 years- Recurrence at 4 months, No evidence of disease after treatment with fludarabine Primary CNS Marginal zone lymphoma

(4) Tu et al. [3] 62F Ataxia NR Dural, left occipital NR Radiation 25 months- No evidence of disease Primary CNS Marginal zone lymphoma

(5) Our case 87F Left sided weakness 6 months Right frontal lobe Lymphoma, vasculitis, or sarcoidosis Rituximab, status post 1st cycle 2 months- patient developed hemorrhagic stroke Low grade B-cell lymphoma with plasmacytic differentiation

NR: not reported; ND: not done.